Orrick Herrington & Sutcliffe LLP advised Guide Therapeutics on the deal. Guide Therapeutics (GuideTx), a developer of nonviral drug delivery vehicles for genetic medicines, announced its acquisition...
This content is for Standard 1 Year members only. LoginJoin Now